Taro Pharma (TARO) Posts Inline Q4 Breakeven Loss
Tweet
Share
E-mailGet Alerts TARO Hot Sheet
Join SI Premium – FREE
Taro Pharma (NYSE: TARO) reported Q4 EPS of $0.00, versus $0.00 reported last year. Revenue for the quarter came in at $244.2 million, versus $881.79 million reported last year.
For earnings history and earnings-related data on Taro Pharma (TARO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amphenol (APH) Tops Q1 EPS by 7c, offers guidance
- Farmers National Banc (FMNB) Tops Q1 EPS by 1c
- Constellium (CSTM) Misses Q1 EPS by 17c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
